Corcept Therapeutics Incorporated (CORT) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Earnings Reports

• Corset Therapeutics (CORT) Q2 2026: Lithioly Launch Adds $47.6M, Accelerating Oncology Expansion
  July 30, 2026
• CourseUp Therapeutics (CORT) Q1 2026: Oncology Launch Captures 200+ Prescribers, Guidance Raised on Endocrine Surge
  May 01, 2026
• CORT Q4 2025: 37% Tablet Volume Gain Reveals Cushing Franchise Demand Surge
  February 25, 2026
• CORT (CORT) Q3 2025: Hypercortisolism Tablets Surge 42.5% as Pipeline Expands Oncology Reach
  November 05, 2025
• CoreSep Therapeutics (CORT) Q2 2025: 49% Prescription Surge Outpaces Pharmacy Capacity, Setting Up Relacorlin Launch
  July 31, 2025
• CORT (CORT) Q1 2025: Relacorilant NDA and 100% Rx Surge Signal Expanding Hypercortisolism Market
  July 06, 2025

Browse all companies